Fabtech Technologies Ltd (FABTECH) — shareholding pattern, promoter holding, financials and share price
About Fabtech Technologies Ltd (FABTECH)
Fabtech Technologies Ltd operates in the Medical Equipment & Supplies industry, within the Healthcare sector. It trades on the NSE as FABTECH and on the BSE under scrip code 544558. Its ISIN is INE0HF201011.
Incorporated in 2018, Fabtech Technologies Ltd is a biopharma engineering company. [1]
Fabtech Technologies Limited is a turnkey life‑sciences engineering platform that designs, engineers, manufactures and validates Process, Air and Water systems for pharmaceutical, biotech and healthcare facilities, delivering start‑to‑finish GMP‑compliant projects across 62 countries with proprietary in‑house manufacturing and project execution capabilities.
The company reported nine‑month FY26 total income of ₹26,309.11 lakhs, but EBITDA and net profit declined materially year‑on‑year due to shipment‑timing effects and front‑loaded project costs, illustrating how shipment‑based revenue recognition can distort quarterly margins despite rising execution activity on the ground.
Listed peers in Medical Equipment & Supplies: OSEL Devices Ltd, Vasa Denticity Ltd, Hemant Surgical Industries Ltd, Prevest Denpro Ltd, Yash Optics & Lens Ltd, Aprameya Engineering Ltd.
Valuation & Returns
10 Jul 2026At ₹159.5 a share on 10 Jul 2026, Fabtech Technologies Ltd (FABTECH) was valued at a price-to-earnings ratio of 18.48x against an industry P/E of 44.11x and a price-to-book of 4.1x on a book value of ₹38.95 per share as of Mar 2025. Solomo computes return on equity of 22.16% and return on capital employed of 20.41% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 18.48x
- Industry P/E
- 44.11x
- P/B
- 4.1x
- EPS (TTM)
- ₹8.63
- Book value / share
- ₹38.95
- ROE
- 22.16%
- ROCE
- 20.41%
- ROA
- 8.99%
- Debt / equity
- 0.48x
- Dividend yield
- 0.38%
- EBITDA margin
- 14.06%
- 52-week range
- ₹126 – ₹262.4
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Fabtech Technologies Ltd (FABTECH) reported revenue of ₹411 crore, net profit of ₹38 crore and earnings per share of ₹8.63. That compares with revenue of ₹327 crore and net profit of ₹46 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹159 crore and net profit ₹22 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 257 | 194 | 226 | 327 | 411 |
| Net profit (₹ cr) | 23 | 22 | 27 | 46 | 38 |
| EPS (₹) | 84.28 | 78 | 92.44 | 14.34 | 8.63 |
| Measure | 5Y | 3Y | 1Y |
|---|---|---|---|
| Sales growth | 12.12% | -2.77% | 44.45% |
| Profit growth | 26.76% | 19.25% | 70.65% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 68.94% of Fabtech Technologies Ltd (FABTECH) (unchanged from the previous quarter), foreign institutional investors (FII) hold 0.02% and domestic institutional investors (DII) hold 2.45%. Market capitalisation was ₹709 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Dec 2025.
Largest disclosed public shareholders in Jun 2026: KEYA VIMAL SALOT 1.41%, HARSHAD RASIKLAL SHETH 1.33%, MAVIRA GROWTH OPPORTUNITIES FUND 1.17%, HUF 1.08%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 68.94% | - | 0.02% | 2.45% | 31.06% |
| Mar 2026 | 68.94% | - | 0.08% | 2.15% | 31.06% |
| Dec 2025 | 68.94% | - | 0.03% | 1.99% | 31.06% |